Understanding The Role of SNORD115-1 in Gene Regulation and Immune Response

Target Name: SNORD115-1

NCBI ID: G338433

SNORD115-1

Other Name(s): Small nucleolar RNA, C/D box 115-1 | small nucleolar RNA, C/D box 115-1 | HBII-52-1 | RNHBII52

Understanding The Role of SNORD115-1 in Gene Regulation and Immune Response

SNORD115-1, also known as small nucleolar RNA (snRNA), is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. Specifically, it is a member of the C/D box RNA family, which includes known snRNAs such ashnRNA, snRNA-1, and snRNA-2.

SnORD115-1 is a 24-nt RNA molecule that contains a unique open reading frame (ORF) of 115-1 nucleotides in the 5'-end. It is predominantly expressed in the nucleolus, where it is involved in the process of mRNA translation initiation.

SnORD115-1 has been shown to play a critical role in the regulation of gene expression in various organisms, including humans. For example, studies have shown that snORD115-1 levels are regulated in response to various cellular stressors, such as nutrient deprivation, UV radiation, and temperature, and that it can also be regulated by various signaling pathways, including TGF-β signaling.

In addition to its role in gene regulation, snORD115-1 has also been shown to be involved in the immune response. Studies have shown that snORD115-1 is transcribed and translated into proteins that are involved in the immune response, including T cells, B cells, and natural killer cells.

Given its involvement in both gene regulation and immune response, snORD115-1 is an attractive drug target or biomarker for a variety of diseases. For example, studies have shown that inhibition of snORD115-1 can enhance the sensitivity of cancer cells to chemotherapy, and that it can also inhibit the development of autoimmune diseases.

In addition to its potential as a drug or biomarker, snORD115-1 also has potential as a research tool for studying gene regulation and protein synthesis. For example, studies have shown that RNA sequencing (RNA-seq) can be used to identify differentially expressed genes in response to various cellular stressors, including those associated with disease.

Overall, snORD115-1 is a fascinating molecule that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in gene regulation and immune response, and to develop effective strategies for its therapeutic use.

Protein Name: Small Nucleolar RNA, C/D Box 115-1

The "SNORD115-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD115-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets